A Phase 1/2 Trial for Patients with Newly Diagnosed High Grade Glioma Treated with Concurrent Radiation Therapy, Temozolomide, and BMX-001
Research Grant
Administered By
Neurosurgery, Neuro-Oncology
Awarded By
BioMimetix JV LLC
Start Date
May 1, 2020
End Date
May 31, 2022
Administered By
Neurosurgery, Neuro-Oncology
Awarded By
BioMimetix JV LLC
Start Date
May 1, 2020
End Date
May 31, 2022